Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis

This publication has 48 references indexed in Scilit:

• Pharmacokinetics of orally administered pirfenidone in male and female beagles
  Journal of Veterinary Pharmacology and Therapeutics, 2004
• Open-label Compassionate Use One Year-treatment with Pirfenidone to Patients with Chronic Pulmonary Fibrosis.
  Internal Medicine, 2002
• Interleukin-18 Regulates Both Th1 and Th2 Responses
  Annual Review of Immunology, 2001
• Interferon-γ 1b: impact of new indications (idiopathic pulmonary fibrosis)
  Expert Opinion on Pharmacotherapy, 2000
• A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary Fibrosis
  New England Journal of Medicine, 1999
• THE EFFECT OF ENOXAPARIN ON BLEOMYCIN-INDUCED LUNG INJURY IN MICE
  Experimental Lung Research, 1999
• Molecular Mechanisms of Antifibrotic Effect of Interferon Gamma in Bleomycin-Mouse Model of Lung Fibrosis: Downregulation of TGF-β and Procollagen I and III Gene Expression
  Experimental Lung Research, 1995
• Lung Cytokine Production in Bleomycin-Induced Pulmonary Fibrosis
  Experimental Lung Research, 1992
• Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
  The Journal of Experimental Medicine, 1989
• Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival
  Thorax, 1980